Figures & data
Table 1 Baseline demographic and clinical characteristics
Table 2 Baseline pharmacotherapy and device therapy
Table 3 Guideline-recommended pharmacotherapy in patients with HFrEF
Table 4 Baseline beta-blocker therapy
Figure 1 Beta-blocker use in heart function clinic study patients.
Figure 2 Target dose achieved for beta blockers prescribed to study patients.
Table 5 Baseline demographic and clinical characteristics and pharmacotherapy of patients fulfilling SHIFT criteria
Table 6 Baseline demographic and clinical characteristics and pharmacotherapy of patients fulfilling SHIFT criteria
Table 7 Outcome of SHIFT eligible patients stratified by the heart rate of <70 bpm versus ≥70 bpm
Table 8 Outcome of SHIFT eligible patients stratified by the heart rate of <75 bpm versus ≥75 bpm
Table 9 Heart function clinic outpatients all cause hospital admissions (May 2014 to March 2016)
Table 10 Heart function clinic outpatients CHF admissions (May 2014 to March 2016)
Figure 3 Kaplan–Meier 23-month survival in the OTMH’s heart function clinic.
Figure 4 Kaplan–Meier 23-month survival according to the resting heart rate and LVEF.
Abbreviation: LVEF, left-ventricular ejection fraction; CI, confidence interval; HR, heart rate.
